Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -48.49% is 27% below its 5-year average of -38.29%, near the low end of its 5-year range (-53.39%–-24.78%).
3.37% above its 12-month average of -50.18%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -11.46%.
RETURN ON ASSETS (ROA)
-48.49%
RETURN ON ASSETS (ROA) AVG TTM
-50.18%
RETURN ON ASSETS (ROA) AVG 3Y
-39.97%
RETURN ON ASSETS (ROA) AVG 5Y
-38.29%
RETURN ON ASSETS (ROA) AVG 10Y
-47.17%
RETURN ON ASSETS (ROA) AVG 15Y
-48.16%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.37%
CURRENT VS 3Y AVG
-21.32%
CURRENT VS 5Y AVG
-26.66%
CURRENT VS 10Y AVG
-2.80%
CURRENT VS 15Y AVG
-0.69%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-50.40%
vs the sector median at left
Aldeyra The
Market Cap
$55.25M
Return on Assets (ROA)
-48.49%
TTM Avg
-50.18%
3Y Avg
-39.97%
5Y Avg
-38.29%
Market Cap
$56.02M
Return on Assets (ROA)
-42.67%
TTM Avg
-85.33%
3Y Avg
-379.34%
5Y Avg
-281.82%
Market Cap
$54.14M
Return on Assets (ROA)
-49.54%
TTM Avg
-66.28%
3Y Avg
-54.88%
5Y Avg
-41.21%
Market Cap
$53.70M
Return on Assets (ROA)
-32404.78%
TTM Avg
-23.59%
3Y Avg
-11.80%
5Y Avg
-9.44%
Market Cap
$57.01M
Return on Assets (ROA)
-98.94%
TTM Avg
-57.19%
3Y Avg
-57.75%
5Y Avg
-128.29%
Market Cap
$57.61M
Return on Assets (ROA)
-56.24%
TTM Avg
-59.70%
3Y Avg
-30.02%
5Y Avg
-37.67%
Market Cap
$52.83M
Return on Assets (ROA)
-54.01%
TTM Avg
-81.00%
3Y Avg
-93.15%
5Y Avg
-65.68%
Market Cap
$57.76M
Return on Assets (ROA)
-37.05%
TTM Avg
-34.36%
3Y Avg
-41.63%
5Y Avg
-37.74%
Market Cap
$52.60M
Return on Assets (ROA)
-15.99%
TTM Avg
-6.85%
3Y Avg
0.40%
5Y Avg
2.07%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aldeyra The (ALDX) | $55.25M | -48.49% | -50.18% | -39.97% | -38.29% |
| OKYO Pharma Limited (OKYO)vs › | $56.02M | -42.67% | -85.33% | -379.34% | -281.82% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $54.14M | -49.54% | -66.28% | -54.88% | -41.21% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | -32404.78% | -23.59% | -11.80% | -9.44% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | -98.94% | -57.19% | -57.75% | -128.29% |
| Talphera, Inc. (TLPH)vs › | $57.61M | -56.24% | -59.70% | -30.02% | -37.67% |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | -54.01% | -81.00% | -93.15% | -65.68% |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | -37.05% | -34.36% | -41.63% | -37.74% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | -15.99% | -6.85% | 0.40% | 2.07% |
| Kalaris Therapeutics Inc (KLRS)vs › | $58.06M | -44.47% | -42.63% | -230.85% | -167.04% |
ROA
-48.5%
ROE
-60.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -46.97% |
| 2024-12-31 | -53.39% |
| 2023-12-31 | -25.31% |
| 2022-12-31 | -34.21% |
| 2021-12-31 | -24.78% |
| 2020-12-31 | -45.05% |
| 2019-12-31 | -80.55% |
| 2018-12-31 | -40.90% |
| 2017-12-31 | -50.57% |
| 2016-12-31 | -74.24% |
| 2015-12-31 | -42.87% |
| 2014-12-31 | -59.03% |
| 2013-12-31 | 348.90% |
| 2012-12-31 | -1167.16% |
| 2011-12-31 | -918.49% |
